Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric Fabry disease.

Markus Ries1, Surya Gupta, David F Moore

  • 1Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 10, Room 3D03, Bethesda, MD 20892-1260, USA. mr380t@nih.gov

Pediatrics
|February 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination gaps in decentralized emergency response: understanding immunization barriers among volunteer firefighters. A cross-sectional mixed methods study.

Frontiers in public health·2026
Same author

Pulmonary nontuberculous mycobacterial infection is associated with urinary molybdenum concentrations in a bronchiectasis cohort.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA.

Therapeutic advances in respiratory disease·2026
Same author

Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib.

Heart rhythm·2025
Same author

Unraveling the Genomic Architecture of Supernumerary (Iso-)Dicentric Chromosomes in Dup15q Syndrome: Insight From a Systematic Literature-Based Study.

American journal of medical genetics. Part A·2025
Same author

Paediatric acute liver failure: A prospective, nationwide, population-based surveillance study in Germany.

Journal of pediatric gastroenterology and nutrition·2025
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
Same journal

Tobacco Use Among Middle and High School Students: 2025 National Youth Tobacco Survey.

Pediatrics·2026
Same journal

Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older.

Pediatrics·2026
See all related articles

Pediatric patients with Fabry disease experience decreased quality of life and sweating, even without major organ dysfunction. Early detection and intervention are crucial for managing this X-linked disorder and preventing long-term complications.

Area of Science:

  • Genetics and rare diseases
  • Pediatric medicine
  • Metabolic disorders

Background:

  • Fabry disease is an underdiagnosed, X-linked, multisystem disorder.
  • Early identification and treatment are essential for managing Fabry disease.
  • The disease affects multiple organ systems, impacting quality of life.

Purpose of the Study:

  • To assess quality of life and sweating function in pediatric Fabry disease patients.
  • To gather quantitative natural history data for therapeutic trials.
  • To identify novel clinical endpoints for future Fabry disease treatments.

Main Methods:

  • Prospective, cross-sectional, observational study design.
  • Involved 25 male children with Fabry disease and 21 age-matched controls.

Related Experiment Videos

  • Assessed quality of life using the Child Health Questionnaire and sweating via the quantitative sudomotor axon reflex test.

    • Main Results:

    • Pediatric Fabry patients reported lower quality of life scores, particularly in bodily pain and mental health.
    • Reduced sweat volume was observed in patients compared to controls.
    • Most patients had normal renal, cardiac, and urinary function, but early signs like acroparesthesia and cardiac abnormalities were noted.

    Conclusions:

    • Fabry disease causes significant morbidity in childhood, even before major organ dysfunction is evident.
    • Identified key outcome measures for future therapeutic trials in pediatric Fabry disease.
    • Long-term therapy should focus on preventing major organ complications.